Christmas Tree and Its Genome Have Remained Very Much the Same Over the Last 100 Million Years
News Jan 11, 2013
A study published by Université Laval researchers and their colleagues from the Canadian Forest Service reveals that the genome of conifers such as spruce, pine, and fir has remained very much the same for over 100 million years. This remarkable genomic stability explains the resemblance between today's conifers and fossils dating back to the days when dinosaurs roamed Earth. Details of this finding are presented in a recent issue of the journal BMC Biology.
The team supervised by Professor Jean Bousquet, who holds the Canada Research Chair in Forest and Environmental Genomics, came to this conclusion after analyzing the genome of conifers and comparing it to that of flowering plants. Both plant groups stem from the same ancestor but diverged some 300 million years ago.
Researchers compared the genome macrostructure for 157 gene families present both in conifers and flowering plants. They observed that the genome of conifers has remained particularly stable for at least 100 million years, while that of flowering plants has undergone major changes in the same period. "That doesn't mean there haven't been smaller scale modifications such as genetic mutations," points out Jean Bousquet. "However, the macrostructure of the conifer genome has been remarkably stable over the ages," adds the professor from the Université Laval Faculty of Forestry, Geography, and Geomatics.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.